It's great to see discussion around PACS Group, Inc. (NYSE: PACS) in the forum. This company operates in the post-acute healthcare sector, primarily focusing on skilled nursing facilities. A data-driven look at PACS reveals several interesting aspects for investors to consider.
Company Overview and Recent Performance
PACS Group, Inc. is a significant player in the post-acute care industry, managing 314 facilities across 17 states as of December 31, 2024, and expanding to 316 facilities by June 30, 2025.1 Their business model centers on acquiring and improving underperforming long-term care facilities. The company has recently been undergoing a process to become current with its SEC filings and restate prior financial statements, with Mark Hancock appointed as interim CFO on September 3, 2025, to oversee this.2 Despite these efforts, PACS anticipates reporting record revenue and Adjusted EBITDA for the first six months of 2025 once filings are complete, indicating strong operational momentum and growth through the addition of 96 facilities since Q2 2024.2
Institutional Ownership and Short Interest
Fintel data shows that PACS has a substantial institutional presence, with 329 institutional owners holding a total of 57.97 million shares. However, there was a -9.53% decrease in institutional shares held quarter-over-quarter.3 Key institutional holders include Cohen & Steers, Inc., Wellington Management Group Llp, and Vanguard Group Inc.3
From a short interest perspective, PACS currently has 2.47 million shares sold short, representing 5.63% of its float. The "Days to Cover" stands at 5.57, suggesting it would take approximately 5.57 days for short sellers to cover their positions based on average trading volume.4 Notably, the off-exchange short volume ratio was 57.05% on August 6, 2025.4
Analyst Sentiment
Analysts maintain a generally positive outlook, with an average one-year price target of $35.09, ranging from a low of $18.18 to a high of $52.50.5 Revenue forecasts project $4,342 million for 2025 and $4,800 million for 2026, with an estimated annual EPS of $2.27 for 2026.6
For those looking to dive deeper, Fintel's platform offers comprehensive data on PACS's institutional ownership, short interest, and financial analysis.
